Australia Single Cell Sequencing Market (2025-2030)
The Australia Single Cell Sequencing Market was valued at $18.6 Million in 2025 and projected to reach to $25.1 Million by 2030, representing a compound annual growth rate of 6.2%. Australia's single cell sequencing market is positioned for steady growth as research institutions and clinical laboratories increasingly adopt advanced genomic technologies.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Australia Single Cell Sequencing Market Trends and Insights
- Australia is experiencing steady adoption of single cell sequencing technologies driven by increasing investment in genomic research infrastructure and growing demand from academic and clinical institutions.
- The market in Australia reflects the broader Asia Pacific trend toward precision medicine, though growth rates remain more moderate compared to global benchmarks, indicating a maturing but still developing market segment. The expansion of Australia's single cell sequencing market is supported by strengthening research capabilities and collaborations between government, universities, and private sector organizations.
- Australia's commitment to biotechnology innovation and the establishment of advanced sequencing facilities have created favorable conditions for market growth through 2030.
- Key drivers include rising prevalence of cancer and genetic disorders, increased funding for life sciences research, and growing adoption of single cell analysis in immunology and developmental biology studies across Australian research institutions..
Key Market Statistics
- CAGR (2025-2030) 6.2% CAGR
- Market Size, 2025 ~USD 18.6 Million
- Forecast, 2030 ~USD 25.1 Million
- Country Australia
Australia Single Cell Sequencing Market Overview
Market Valuation :
Australia's single cell sequencing market is valued at $18.6 million in 2025, with projected growth to $25.1 million by 2030, reflecting steady market expansion in the Asia-Pacific region.
Growth Trajectory :
The Australian market demonstrates a 6.2% CAGR through 2030, outpacing broader economic growth and indicating strong institutional adoption of advanced genomic technologies.
Research Infrastructure Investment :
Increasing government and private sector investment in genomic research facilities across Australian universities and medical centers is driving demand for single cell sequencing platforms and services.
Clinical and Academic Adoption :
Growing adoption from Australian academic institutions and clinical laboratories reflects expanding applications in cancer research, immunology, and personalized medicine initiatives.
Australia Single Cell Sequencing Market Dynamics
- The 6.2% CAGR reflects strong institutional investment in genomic infrastructure and growing recognition of single cell sequencing's value in precision medicine and disease research.
- Key drivers include expanding collaborations between Australian research centers and international genomics initiatives, coupled with rising demand for personalized treatment approaches in oncology and immunotherapy. The market outlook remains positive through 2030, supported by government funding for life sciences research and growing private sector participation.
- Australian biotech companies and CROs are increasingly incorporating single cell sequencing into their service offerings, while academic institutions continue to establish dedicated genomics centers.
- Competitive pricing pressures and technology standardization are expected to accelerate adoption across mid-tier research facilities and regional medical centers..
Related Ecosystem
Advanced Genetic Sequencing
- Polymerase Chain Reaction (PCR)
- Reagents
- Assay Kits
- Bioinformatics
- Flow Cytometry
- Thermo Fisher Scientific Inc.
- Illumina, Inc.
- Agilent Technologies, Inc.
- Qiagen N.V.
- Danaher Corporation
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- Australia's single cell sequencing market is projected to grow from $18.6M (2025) to $25.1M (2030) at a 6.2% CAGR.
- Australia's market growth is driven by increased genomic research funding and adoption in academic and clinical settings.
- Australia's single cell sequencing adoption is supported by government initiatives and biotechnology infrastructure development.
- Australia's market represents a steady but moderate growth trajectory within the Asia Pacific region through 2030.
Single Cell Sequencing Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | SERVICES (Offering) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 12.2% from 2025 to 2030 |
| Largest Segment | PRODUCTS (Offering) |
| Market Size Base Year (Billions) | ~USD 1.95 (2025) |
| Revenue Forecast (Billions) | ~USD 3.46 (2030) |
| Segments Covered | Offering, Type, End User, Sequencing Type, Application, Workflow |
Australia Single Cell Sequencing Market Report Segmentation
6 segment dimensions are covered across the global market.
By Offering
- Products
- Services
By Type
- Basic & Translational Research
- Cancer Research
- Cell Sorters
- Consumables
- Data Analysis & Bioinformatics Services
- Data Storage & Management Software
- Drug Discovery & Development
- Instruments
- Lcm Instruments
- Library Preparation Services
- Microbiology & Infectious Diseases
- Microfluidic Instruments
- Neurology & Brain Research
- Organ Development & Regenerative Medicine
- Other Pre-Sequencing Instruments
- Pcr Instruments
- Pre-Sequencing Instruments
- Pre-Sequencing Reagents & Kits
- Pre-Sequencing Services
- Sample Preparation, Single-Cell Isolation, And Enrichment Services
- Sequencing Platforms
- Sequencing Reagents & Kits
- Sequencing Services
- Software
- Software Tools
- Stem Cell & Developmental Biology
By End User
- Academic & Research Institutes
- Biotechnology & Pharmaceutical Companies
- Cros
- Hospitals & Clinical Laboratories
- Pharmaceutical & Biopharmaceutical Companies
By Sequencing Type
- Other Single-Cell Sequencing Types
- Scatac-Seq
- Scdna-Seq
- Scrna-Seq
By Application
- Diagnostic & Clinical Applications
- Research Applications
By Workflow
- Data Analysis & Interpretation
- Pre-Sequencing
- Sequencing
AUSTRALIA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ACADEMIC & RESEARCH INSTITUTES | 8.23 | 7.96 | 7.79 | 7.92 | 8.27 | 8.85 | 9.63 | 10.61 | 6.4 |
| CROS | 2.03 | 1.94 | 1.88 | 1.88 | 1.94 | 2.05 | 2.2 | 2.39 | 5 |
| HOSPITALS & CLINICAL LABORATORIES | 3.81 | 3.66 | 3.55 | 3.58 | 3.71 | 3.93 | 4.24 | 4.64 | 5.5 |
| PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES | 5.65 | 5.49 | 5.39 | 5.49 | 5.76 | 6.18 | 6.74 | 7.46 | 6.7 |
| TOTAL | 19.7 | 19.1 | 18.6 | 18.9 | 19.7 | 21 | 22.8 | 25.1 | 6.2 |
AUSTRALIA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ACADEMIC & RESEARCH INSTITUTES | 2.2 | 2.41 | 2.51 | 2.7 | 2.94 | 3.27 | 3.72 | 4.31 | 11.4 |
| BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES | 2.06 | 2.27 | 2.38 | 2.57 | 2.82 | 3.15 | 3.6 | 4.2 | 12 |
| HOSPITALS & CLINICAL LABORATORIES | 1.45 | 1.57 | 1.61 | 1.69 | 1.81 | 1.98 | 2.21 | 2.51 | 9.4 |
| TOTAL | 5.71 | 6.25 | 6.5 | 6.96 | 7.57 | 8.4 | 9.53 | 11.02 | 11.1 |
Target Audience
- Genomics Equipment Manufacturers : Need Australia-specific market data to assess demand for single cell sequencing platforms, identify key institutional buyers, and develop region-appropriate sales and support strategies.
- Clinical Laboratory Operators : Require market insights to evaluate service expansion opportunities, benchmark pricing against competitors, and understand adoption trends among Australian healthcare providers.
- Research Institution Leaders : Need market intelligence to justify genomics infrastructure investments, identify funding opportunities, and benchmark their capabilities against peer institutions in Australia.
- Biotech and CRO Companies : Seek Australia market data to evaluate service offerings, identify partnership opportunities with research centers, and understand demand for genomic analysis services.
- Healthcare Investors and Consultants : Require detailed market analysis to assess investment opportunities in Australian genomics companies, evaluate market growth potential, and inform strategic advisory recommendations.
Reasons to Buy this Report
- Market-Specific Sizing : Obtain precise valuation data for Australia's single cell sequencing market with detailed 2025-2030 forecasts, enabling accurate budget allocation and investment planning for regional expansion.
- Competitive Landscape Intelligence : Understand key players, technology providers, and service offerings specific to the Australian market to identify partnership opportunities and competitive positioning strategies.
- Growth Driver Analysis : Identify Australia-specific factors driving adoption including research funding trends, institutional priorities, and regulatory environment to inform go-to-market strategies.
- Customer Segmentation Insights : Access detailed breakdown of demand across Australian academic institutions, clinical laboratories, and biotech companies to target high-value customer segments effectively.
- Regional Expansion Strategy : Leverage Australia-focused market intelligence to develop localized business strategies, pricing models, and partnership approaches for successful market entry or growth.
Frequently asked questions
What is the current market size of single cell sequencing in Australia?
Australia's single cell sequencing market is valued at $18.6 million in 2025.
What is the projected market size for single cell sequencing in Australia by 2030?
Australia's single cell sequencing market is forecast to reach $25.1 million by 2030.
What is the CAGR for Australia's single cell sequencing market?
Australia's single cell sequencing market is expected to grow at a compound annual growth rate of 6.2% from 2025 to 2030.
What are the primary drivers of growth in Australia's single cell sequencing market?
Key drivers in Australia include increased genomic research funding, rising prevalence of genetic disorders, adoption in immunology research, and strengthening biotechnology infrastructure.
How does Australia's single cell sequencing market compare to global trends?
Australia's 6.2% CAGR is more moderate than the global 12.2% CAGR, reflecting a maturing market with steady but measured growth within the Asia Pacific region.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global single-cell sequencing market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the single cell sequencing market. The secondary sources used for this study The secondary sources used for this study include the World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), the International Clinical Cytometry Society (ICCS), the International Society for Advancement of Cytometry (ISAC), the National Institutes of Health (NIH), the Organisation for Economic Co-operation and Development (OECD), and the Society for Laboratory Automation and Screening (SLAS); Corporate and Regulatory Filings, Annual Reports, Sec Filings, Investor Presentations, and Financial Statements; Business Magazines & Research Journals; Press Releases, MarketsandMarkets Analysis. These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global single-cell sequencing market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (personnel from, pharmaceutical & and biotechnology companies, hospitals & diagnostic laboratories, academic & research institutes, and contract research organization) and supply side (C-level and D-level executives, product managers, and marketing and sales managers of key manufacturers, distributors, and channel partners, among others, across six major regions—North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa. Approximately 70% of primary interviews were conducted with supply-side representatives, while demand-side participants accounted for the remaining share. This preliminary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the single-cell sequencing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Single Cell Sequencing Market : Top-Down and Bottom-Up Approach
Data Triangulation
After arriving at the overall market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable.
Market Definition
Single-cell sequencing (SCS) is a genomic technology that allows researchers to study the genetic material of individual cells. Unlike traditional sequencing methods that analyze bulk cell populations, single-cell sequencing helps identify differences between individual cells, providing a clearer understanding of cell functions, disease mechanisms, and treatment responses. The scope of the single-cell sequencing market includes a wide range of products and services used across the entire single-cell workflow. This covers pre-sequencing instruments and consumables (such as cell isolation tools and library preparation kits), sequencing instruments and consumables, and software for analyzing single-cell data. The market also includes services provided by third parties across pre-sequencing, sequencing, and data analysis stages. The market also studies various sequencing types, including single-cell RNA sequencing (scRNA-seq), single-cell DNA sequencing (scDNA-seq), and single-cell ATAC sequencing (scATAC-seq), among others. These technologies are widely used in basic and translational research, drug discovery, and clinical applications, especially in cancer, neurological, and infectious diseases. End users of these solutions studied in the report include academic and research institutions, pharmaceutical and biotechnology companies, hospitals and diagnostic labs, and contract research organizations (CROs).
Stakeholders
- Academic & Research Institutes
- Single-cell Sequencing Assay & Reagent Manufacturers, Vendors, and Distributors
- Contract Research Organizations (CROs)
- Single-cell Sequencing Service & Software Providers
- Diagnostics Companies
- Market Research & Consulting Firms
- Pharmaceutical & Biotechnology Companies
- Regulatory Agencies
- Venture Capitalists
- Government organizations
- Contract Development & Manufacturing Organizations (CDMOs)
- Hospitals and Diagnostic Laboratories
Report Objectives
- To define, describe, and forecast the global single-cell sequencing market based on offering, product type, product workflow, product end user, service type, service end user, sequencing type, application, and region
- To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six central regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To profile the key players in the global single-cell sequencing market and comprehensively analyze their core competencies and market shares
- To track and analyze competitive developments such as acquisitions, product launches & approvals, expansions, agreements, partnerships, and collaborations in the single-cell sequencing market
- To benchmark players in the single-cell sequencing market using the “Company Evaluation Matrix” framework, which analyzes market players based on various parameters, including product portfolio, geographic reach, and market share
Available Customizations
With the given market data, MarketsandMarkets offers customizations to meet the company’s needs. The following customization options are available for the report:
Geographical Analysis
- Further breakdown of the Rest of Europe’s single-cell sequencing market, by country
- Further breakdown of the Rest of Asia Pacific’s single-cell sequencing market, by country
- Further breakdown of the Rest of Latin America’s single-cell sequencing market, by country
- Further breakdown of the Rest of the Middle East’s single-cell sequencing market, by country
Company Information
- Detailed analysis and profiling of additional market players (up to five)
Segment Analysis
- Further breakdown of the other technologies into subsegments
- Cross-segment analysis
Get the Full Single Cell Sequencing Market Report
Full forecast, segment splits, and company analysis for all Single Cell Sequencing Market.
- US Single Cell Sequencing Market
- Canada Single Cell Sequencing Market
- UK Single Cell Sequencing Market
- Germany Single Cell Sequencing Market
- France Single Cell Sequencing Market
- Italy Single Cell Sequencing Market
- Spain Single Cell Sequencing Market
- China Single Cell Sequencing Market
- Japan Single Cell Sequencing Market
- India Single Cell Sequencing Market
- South Korea Single Cell Sequencing Market
- Brazil Single Cell Sequencing Market
- Mexico Single Cell Sequencing Market
- Rest Of Europe Single Cell Sequencing Market
- Rest Of Asia Pacific Single Cell Sequencing Market
- Rest Of Latin America Single Cell Sequencing Market
- Ksa Single Cell Sequencing Market
- Other GCC Countries Single Cell Sequencing Market
- UAE Single Cell Sequencing Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
